Global Medical Device Leaders Report Strong Q1 2025 Financial Performance Amid Strategic Expansions

• Abbott

Abbott Announces First Quarter 2025 Results. Net sales for the quarter were $10.358 billion, compared to $9.964 billion in the same period last year, representing a 4% increase year-over-year. Operating profit for the quarter was $1.693 billion, compared to $1.386 billion in the same period last year, reflecting a 22.1% year-over-year growth. Net earnings for the quarter were $1.325 billion, compared to $1.225 billion in the same period last year. Among the segments, nutrition business sales were $2.146 billion, diagnostics business sales were $2.054 billion, pharmaceuticals business sales were $1.26 billion, and medical devices business sales were $4.895 billion.

• Siemens Healthineers

Siemens Healthineers Releases Financial Results for the Second Quarter Ended March 31, 2025. Quarterly revenue was €5.909 billion (approximately $6.69 billion), compared to €5.435 billion in the same period last year, representing an 8.7% year-over-year increase. Adjusted EBIT profit for the quarter was €982 million, up from €822 million in the same period last year, marking a year-over-year increase.19%. Quarterly net profit of 537 million euros, compared to 431 million euros in the same period last year, a year-on-year increase of 25%.

Medical device and equipment manufacturer Stryker announced its first-quarter results for 2025. Net sales for the quarter were $5.866 billion, compared to $5.243 billion in the same period last year, representing an 11.9% year-over-year increase. Operating profit for the quarter was $837 million, down 13.9% from $972 million in the same period last year. Net profit for the quarter was $654 million, a decrease of 17% from $788 million in the same period last year.

• Danaher

Danaher Announces First Quarter 2025 Results. Quarterly sales were $5.741 billion, compared to $5.796 billion in the same period last year. Quarterly operating profit was $1.274 billion, compared to $1.312 billion in the same period last year. Quarterly net profit was $954 million, compared to $1.088 billion in the same period last year.

• BD

BD Reports Second Fiscal Quarter Results Ended March 31, 2025. Quarterly revenue was $5.272 billion, compared to $5.045 billion in the same period last year, representing a year-over-year increase of 4.5%. Quarterly operating profit was $546 million, compared to $734 million in the same period last year, reflecting a year-over-year decrease of 25.5%. Quarterly net profit was $308 million, compared to $537 million in the same period last year, marking a year-over-year decline of 42.7%.

• Fresenius

Fresenius Medical Care Releases First Quarter 2025 Financial Results. Total quarterly revenue reached €4.881 billion (approximately $5.53 billion), compared to €4.725 billion in the same period last year, representing a year-over-year increase of 3.3%. Quarterly operating profit amounted to €331 million, up from €246 million in the same period last year, marking a 34.7% year-over-year increase. Net profit attributable to shareholders of the company for the quarter was €151 million, compared to €71 million in the same period last year, reflecting a 113% year-over-year growth.

• Thermo Fisher Scientific

Thermo Fisher Scientific Announces First Quarter 2025 Financial Results. Quarterly revenue was $10.364 billion, compared to $10.345 billion in the same period last year. Quarterly operating profit was $1.716 billion, compared to $1.663 billion in the same period last year. Net profit attributable to the company for the quarter was $1.507 billion, compared to $1.328 billion in the same period last year. Among these figures, Life Sciences business revenue was $2.341 billion, Laboratory Products and Biopharma Services revenue was $5.64 billion, Specialty Diagnostics business revenue was $1.148 billion, and Analytical Instruments revenue was $1.718 billion.

• GE Healthcare

GE HealthCare Reports First Quarter 2025 Results. Total revenue for the quarter was $4.777 billion, compared to $4.65 billion in the same period last year. Operating profit for the quarter was $629 million, compared to $540 million in the same period last year. Net income attributable to the company for the quarter was $564 million, compared to $374 million in the same period last year.

• Boston Scientific

Boston Scientific Reports First Quarter 2025 Results. Net sales for the quarter were $4.663 billion, compared to $3.856 billion in the same period last year. Operating profit for the quarter was $921 million, compared to $675 million in the same period last year. Net income attributable to common shareholders for the quarter was $674 million, compared to $495 million in the same period last year.

• Philips

Philips Releases First Quarter 2025 Results. Quarterly sales reached 4.097 billion euros (approximately 4.64 billion US dollars), compared to 4.138 billion euros in the same period last year. Quarterly operating profit was 154 million euros, compared to an operating loss of 824 million euros in the same period last year. Quarterly net profit was 72 million euros, compared to a net loss of 998 million euros in the same period last year.

• Roche

Roche Announces Q1 2025 Results: Group Sales Reach CHF 15.4 Billion, Up from CHF 14.4 Billion in the Same Period Last Year

• Cardinal Health

Cardinal Health Reports Third Quarter Fiscal 2025 Results Ended March 31, 2025. Quarterly revenue was $54.9 billion, compared to $54.9 billion in the same period last year. Net income attributable to the company for the quarter was $506 million, compared to $261 million in the same period last year. Revenue from medical products and distribution business was $3.2 billion, compared to $3.1 billion in the same period last year; quarterly profit was $39 million, compared to $22 million in the same period last year.

• Henry Schein

Henry Schein Reports First Quarter 2025 Results. Net sales for the quarter were $3.168 billion, compared to $3.172 billion in the same period last year. Operating profit for the quarter was $175 million, compared to $150 million in the same period last year. Net income attributable to the company for the quarter was $110 million, compared to $93 million in the same period last year.

• Olympus-Medical

Owens & Minor Announces First Quarter 2025 Results. Net revenue for the quarter was $2.632 billion, compared to $2.613 billion in the same period last year. Operating profit for the quarter was $124,000, compared to $9.7 million in the same period last year. Net loss for the quarter was $24.98 million, compared to a net loss of $21.89 million in the same period last year.

• Baxter

Baxter International Announces First Quarter 2025 ResultsFirst quarter net sales were $2.625 billion, compared to $2.49 billion in the same period last year, representing a 5% year-over-year increase. Operating profit for the quarter was $58 million, down 50% from $115 million in the same period last year. Net income attributable to shareholders for the quarter was $126 million, compared to $37 million in the same period last year.

• Intuitive Surgical

Intuitive Surgical Announces First Quarter 2025 Financial Results. Total revenue for the quarter was $2.253 billion, compared to $1.891 billion in the same period last year. Operating profit for the quarter was $578 million, compared to $469 million in the same period last year. Net profit attributable to the company for the quarter was $698 million, compared to $545 million in the same period last year.

• Sulvanus

(Solventum, formerly 3M Health Care Business) Announces First Quarter 2025 Results. Total net sales for the quarter were $2.07 billion, compared to $2.016 billion in the same period last year. Operating profit for the quarter was $152 million, compared to $381 million in the same period last year. Net profit for the quarter was $137 million, compared to $237 million in the same period last year.

• Zimmer Biomet

Zimmer Biomet Holdings Reports First Quarter 2025 Results. Net sales for the quarter were $1.909 billion, compared to $1.889 billion in the same period last year. Operating profit for the quarter was $292 million, compared to $266 million in the same period last year. Net income attributable to the company for the quarter was $182 million, compared to $172 million in the same period last year.

• Terumo

Terumo Announces Financial Results for the Fiscal Year Ended March 31, 2025. Full-year revenue reached 1,036.2 billion yen (approximately $7.212 billion USD), compared to 921.9 billion yen the previous year, representing a year-over-year increase of 12.4%. Annual operating profit was 157.7 billion yen, up from 140.1 billion yen the previous year, marking a growth of 12.5%. Net profit attributable to owners of the parent company for the full year was 117 billion yen, compared to 106.4 billion yen the previous year, reflecting a year-over-year increase of 10%.

• Fujifilm

Fujifilm Holdings Announces Financial Results for the Fiscal Year Ending March 31, 2025. Full-year revenue reached 3,195.8 billion yen, compared to 2,960.9 billion yen in the previous year, representing a 7.9% year-on-year increase. Annual operating profit was 330.2 billion yen, up from 276.7 billion yen the previous year, marking a 19.3% increase. Net profit attributable to the company for the full year was 261 billion yen, compared to 243.5 billion yen the previous year, an increase of 7.2%. By business segment, revenue from the healthcare business grew by 4.9% to 1,022.6 billion yen (approximately 7.12 billion U.S. dollars). Revenue from the electronic materials business increased by 20.7% to 432.8 billion yen. Revenue from the imaging business rose by 15.4% to 542 billion yen. Revenue from the business innovation segment grew by 3.5% to 1,198.5 billion yen.

• Olympus

Olympus (OLYMPUS) Announces Financial Results for the Fiscal Year Ended March 31, 2025. Full-year revenue reached 997.3 billion yen (approximately 6.94 billion USD), compared to 925.8 billion yen in the previous year, representing a 7.7% year-on-year increase. Annual operating profit was 162.5 billion yen, up from 51.4 billion yen the previous year, marking a 216% year-on-year increase. Net profit attributable to owners of the parent company for the full year was 117.9 billion yen, down from 242.6 billion yen in the previous year, reflecting a 51.4% year-on-year decrease.

• Mindray Medical

Mindray Medical Announces Q1 2025 Revenue of 8.237 Billion Yuan (Approx. 11.44 Billion USD), Down 12.12% Year-over-Year; Net Profit Attributable to Shareholders of 2.629 Billion Yuan, Down 16.81% Year-over-Year.

• Canon Group

Canon Group Announces Q1 2025 Financial Results. Net sales for the quarter reached 1,058.396 billion yen, compared to 988.519 billion yen in the same period last year. Operating profit for the quarter was 96.517 billion yen, up from 80.083 billion yen in the previous year. Net profit attributable to the company for the quarter amounted to 72.231 billion yen, compared to 59.949 billion yen in the same period last year. By business segment, net sales in the printing sector were 610.965 billion yen, while net sales in the medical sector reached 137.333 billion yen (approximately 956 million USD). In the imaging sector, net sales were 212.096 billion yen, and in the industrial sector, net sales totaled 67.468 billion yen.

• EssilorLuxottica

EssilorLuxottica Reports Q1 2025 Financial Results. Total revenue for the quarter reached €6.848 billion, compared to €6.335 billion in the same period last year. Revenue from professional businesses amounted to €3.236 billion (approximately $3.665 billion), up from €3.08 billion in the prior-year period. Consumer business revenue was €3.612 billion, compared to €3.255 billion in the same period last year.

• Alcon

Alcon Announces First Quarter 2025 Results. Net sales for the quarter were $2.451 billion, compared to $2.444 billion in the same period last year. Operating profit for the quarter was $468 million, compared to $368 million in the same period last year. Net income attributable to the company's shareholders for the quarter was $350 million, compared to $248 million in the same period last year.

• Bausch + Lomb

Bausch+Lomb Reports First Quarter 2025 Results. Revenue for the quarter was $1.137 billion, compared to $1.099 billion in the same period last year. Operating loss for the quarter was $83 million, compared to an operating profit of $6 million in the same period last year. Net loss attributable to the company for the quarter was $212 million, compared to a net loss of $167 million in the same period last year.